Key result
Current smoking is linked to significantly higher serum phosphate and triglyceride levels across sexes.
Why the study?
Both low and high serum phosphate levels may be associated with CVD morbidity and mortality, and smoking increases type 2 diabetes risk. Whether smoking and type 2 diabetes are associated with serum phosphate and triglyceride levels independently of other CVD risk factors required investigation.
Are current smoking and type 2 diabetes independently associated with serum phosphate and triglyceride levels in patients with cardiovascular disease risk factors?
Cross-Sectional (n=2,504)
No
Are current smoking and type 2 diabetes independently associated with serum phosphate and triglyceride levels in patients with cardiovascular disease risk factors?
Answers are grounded in this paper and cite their sources.
Cigarette smoking is independently associated with elevated serum phosphate and triglyceride levels in patients with cardiovascular risk factors, suggesting smoking must be accounted for as a confounder when evaluating serum phosphate as a cardiovascular risk marker.
BACKGROUND: Both low and high serum phosphate levels may be associated with morbidity and mortality from cardiovascular disease. As smoking increases risk for type 2 diabetes (as shown by dyslipidemia and hyperglycemia), we wanted to study whether smoking and type 2 diabetes were associated with serum phosphate and triglyceride levels independently from other CVD risk factors. METHODS: Upon admittance to the Vindeln Health Education Centre (VHE-centre) for a four-week comprehensive lifestyle intervention, the participants (1408 women and 1096 men) completed a questionnaire that included their smoking habits - current smoker or non-smoker. We used multiple linear regression analyses to investigate the association between smoking and other CVD risk factors with S-P and S-TG levels. RESULTS: In the non-type 2 diabetes populations, the smokers, compared to the non-smokers, had higher S-P and higher serum triglycerides (S-TG). In women, serum-TG in smokers with type 2 diabetes was higher than in smokers with non-type 2 diabetes. Non-type 2 diabetes patients exhibited an inverse relation between S-Glucose (S-Glu) and S-P and a positive association with S-TG. For men only, an association was seen between age (-) and S-Crea (-) and S-P. For women only, an association was seen between BMI (-) and S-Cholesterol (+) (S-Chol) and S-P. CONCLUSIONS: Compared to non-smokers, smoking women with non-type 2 diabetes and smoking men with type 2 diabetes had a higher level of S-P and S-TG. The association between smoking and S-P and S-TG levels still existed after adjusting for age and CVD risk factors in the multiple linear regression analyses. TRIAL REGISTRATION: The study has been registered as a sub-study to the Lifestyle Intervention Trial no. ISRCTN79355192.
No takes yet. Share an insight, caveat, or question.
Håglin et al. (2014) conducted a cross-sectional in Cardiovascular disease risk factors and type 2 diabetes (n=2,504). Current smoking vs. Non-smokers (including former smokers) was evaluated on Serum phosphate (S-P) and serum triglyceride (S-TG) levels (p=0.047 in women and 0.032 in men for S-P; 0.003 in women and 0.000 in men for S-TG). Current smoking was independently associated with higher serum phosphate and triglyceride levels after adjusting for CVD risk factors.
Synapse has enriched 10 related papers. Consider them for comparative context: